Shanghai Kindly Enterprise Development Group Co.,LTD.(603987.SS)
No price history available.
Key financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNYm | 2,645 | 3,097 | 3,119 | 2,453 | 2,261 | 2,298 | N/A | N/A |
| Operating profit | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | CNYm | 203 | 291 | 312 | 231 | 215 | 240 | N/A | N/A |
| EPS reported | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Shanghai Kindly Enterprise Development Group Co.,LTD. (603987.SS) is a global manufacturer and distributor of disposable medical polymer products. The company's core offerings include essential medical devices such as syringes, infusion and transfusion sets, various medical tubes, needles, cannulas, and specialized medical bags. Beyond these primary instruments, they supply a comprehensive range of medical packaging materials, including PPPE composite films, dedicated medical packing films, sterilization indicator strips, Bowie Dick test packs, sterilization indicator tapes, medical wrapping papers, paper bags, and sterilization reels. Their extensive portfolio also features interventional accessories crucial for various procedures, encompassing guide wires, Y-connectors, inflation devices, manifold kits, pressure bandages, angiography syringes, stopcocks, sterile Seldinger needles, introducer sets and accompanying tool kits, pressure transducers, extension tubes, hemostasis balloons, extension lines equipped with needle-free valves, pressure monitoring tubing products, and spine tool kits. Furthermore, they provide a variety of catheters, including guiding, micro, and angiography catheters. Additional products comprise self-sealing pouches, Tyvek® reels, mini-spikes, PE extension tubes, and essential accessories like heparin caps, umbilical cord clamps, and safety boxes. The company also furnishes pre-packaged medical solutions, including suction catheter kits, irrigation kits, and puncture sets. Founded in 1987, Shanghai Kindly Enterprise Development Group Co.,LTD. maintains its headquarters in Shanghai, China.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Shanghai Kindly Enterprise Development Group Co.,LTD. (603987.SS)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Shanghai Kindly Enterprise Development Group Co.,LTD. (603987.SS) is a global manufacturer and distributor of disposable medical polymer products. The company's core offerings include essential medical devices such as syringes, infusion and transfusion sets, various medical tubes, needles, cannulas, and specialized medical bags. Beyond these primary instruments, they supply a comprehensive range of medical packaging materials, including PPPE composite films, dedicated medical packing films, sterilization indicator strips, Bowie Dick test packs, sterilization indicator tapes, medical wrapping papers, paper bags, and sterilization reels. Their extensive portfolio also features interventional accessories crucial for various procedures, encompassing guide wires, Y-connectors, inflation devices, manifold kits, pressure bandages, angiography syringes, stopcocks, sterile Seldinger needles, introducer sets and accompanying tool kits, pressure transducers, extension tubes, hemostasis balloons, extension lines equipped with needle-free valves, pressure monitoring tubing products, and spine tool kits. Furthermore, they provide a variety of catheters, including guiding, micro, and angiography catheters. Additional products comprise self-sealing pouches, Tyvek® reels, mini-spikes, PE extension tubes, and essential accessories like heparin caps, umbilical cord clamps, and safety boxes. The company also furnishes pre-packaged medical solutions, including suction catheter kits, irrigation kits, and puncture sets. Founded in 1987, Shanghai Kindly Enterprise Development Group Co.,LTD. maintains its headquarters in Shanghai, China.
